AK146D1 for injection

DRUG5 trials

Sponsors

Akeso

Conditions

Advanced Breast CancerAdvanced Non Small Cell Lung Cancer (NSCLC)Advanced Solid TumorsUrothelial Carcinoma (UC)

Phase 1

A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors

RecruitingNCT06929663

AkesoAdvanced Solid Tumors

Start: 2025-07-02End: 2027-05-05Target: 48Updated: 2025-07-17

A Study of AK146D1 for Injection in Advanced Solid Tumors

RecruitingNCT07067567

AkesoAdvanced Solid Tumors

Start: 2025-08-07End: 2027-05-05Target: 200Updated: 2025-09-03

Phase 2

A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer

RecruitingNCT07591090

AkesoAdvanced Breast Cancer

Start: 2026-07-17End: 2029-02-04Target: 200Updated: 2026-07-22

A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial Carcinoma

Not yet recruitingNCT07636772

AkesoUrothelial Carcinoma (UC)

Start: 2026-06-22End: 2028-08-24Target: 132Updated: 2026-06-09

A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer

RecruitingNCT07669779

AkesoAdvanced Non Small Cell Lung Cancer (NSCLC)

Start: 2026-07-10End: 2029-05-30Target: 348Updated: 2026-07-14